Cimicifuga racemosa (L.) Nutt. in the treatment of vasomotor symptoms of menopause: a review

被引:0
作者
Garcia-Bienes, Hilaria M. [1 ]
Sanchez-Mateo, Candelaria C. [1 ]
机构
[1] Univ La Laguna, Fac Farm, Dept Med Fis & Farmacol, San Cristobal la Laguna, Spain
关键词
Cimicifuga racemosa; menopause; hot flushes; vasomotor symptoms; review; DOUBLE-BLIND; BLACK COHOSH; CLIMACTERIC COMPLAINTS; ETHANOLIC EXTRACT; EFFICACY; TOLERABILITY; WOMEN;
D O I
10.30827/ars.v63i2.21894
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Several studies have shown that preparations based on the rhizomes and roots of black cohosh (Cimicifuga racemosa (L.) Nutt.) can be useful in alleviating the menopausal symptoms. The aim of this study is to perform an update bibliographic review of the efficacy and safety of black cohosh in the treatment of the vasomotor symptoms of menopause. Method: A review of published articles from January 2005 to March 2021 in the resource search engine of the University of La Laguna, el punto Q". Randomized and controlled clinical trials, which had the key words in the abstract, text or title, in both English and Spanish, were selected. Results: We found 13 trials which met the selection criteria. The studies reviewed showed that the black cohosh preparations (mainly commercial extracts standardized in their content of active ingredients) produced in most of the studies a significant reduction compared to placebo in the vegetative (hot flashes and night sweats) and psychological symptoms of menopause, as well as an improvement in the quality of life. No serious adverse effects were reported at the dose administered. Conclusions: Cimicifuga racemosa extracts can be effective and safe for the treatment of vegetative and psychological symptoms of menopause, being well tolerated. However, more clinical trials with a larger number of patients, more extensive, the use of standardized preparations, as well as similar criteria for inclusion and assessment of symptoms, are necessary to obtain more conclusive data.
引用
收藏
页码:178 / 188
页数:11
相关论文
共 50 条
  • [31] Bazedoxifene plus conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause
    Tella, Sri Harsha
    Gallagher, John Christopher
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (17) : 2407 - 2420
  • [32] A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms
    David, Paru S.
    Smith, Taryn L.
    Nordhues, Hannah C.
    Kling, Juliana M.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2022, 14 : 353 - 361
  • [33] Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment
    Rapkin, Andrea J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (02) : 97 - 106
  • [34] Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
    Sarri, G.
    Pedder, H.
    Dias, S.
    Guo, Y.
    Lumsden, M. A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (10) : 1514 - 1523
  • [35] Economical, Plain, and Rapid Authentication of Actaea racemosa L. (syn. Cimicifuga racemosa, Black Cohosh) Herbal Raw Material by Resilient RP-PDA-HPLC and Chemometric Analysis
    Bittner, Marian
    Schenk, Regina
    Springer, Andreas
    Melzig, Andmatthias F.
    PHYTOCHEMICAL ANALYSIS, 2016, 27 (06) : 318 - 325
  • [36] Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
    Elnaga, Ahmed A. Abo
    Alsaied, Mohamed A.
    Elettreby, Abdelrahman M.
    Ramadan, Alaa
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 297 : 142 - 152
  • [37] Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms
    Bonga, Krishna Nikhila
    Mishra, Archana
    Maiti, Rituparna
    Padhy, Biswa Mohan
    Meher, Bikash Ranjan
    Srinivasan, Anand
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (03) : 393 - 402
  • [38] Assessment of women's treatment preferences for vasomotor symptoms due to menopause
    Shiozawa, Aki
    Thurston, Rebecca C.
    Cook, Erin
    Yang, Hongbo
    King, Deanna D.
    Kristy, Rita M.
    Mancuso, Shayna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (10) : 1117 - 1128
  • [39] Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis
    Chavez, Matheus Pedrotti
    Pasqualotto, Eric
    Ferreira, Rafael Oliva Morgado
    Hohl, Alexandre
    de Moraes, Francisco Cezar Aquino
    Schmidt, Pedro Henrique Siedschlag
    Rodrigues, Anna Luiza Soares de Oliveira
    de Sa, Joao Roberto
    CLIMACTERIC, 2024, 27 (03) : 245 - 254
  • [40] Nonpharmacologic, nonherbal management of menopause-associated vasomotor symptoms: An umbrella systematic review (protocol)
    Goldstein K.M.
    McDuffie J.R.
    Shepherd-Banigan M.
    Befus D.
    Coeytaux R.R.
    Van Noord M.G.
    Goode A.P.
    Masilamani V.
    Adam S.
    Nagi A.
    Williams J.W.
    Systematic Reviews, 5 (1)